(Q52372230)

30 April 2018

review article

1 reference

title

[Obesity studies in candidate genes]. (English)

1 reference

30 April 2018

0 references

2

1 reference

30 April 2018

author name string

María del Carmen Ochoa

series ordinal

1

1 reference

30 April 2018

J Alfredo Martínez

series ordinal

3

1 reference

30 April 2018

language of work or name

Spanish

0 references

publication date

1 April 2004

1 reference

30 April 2018

published in

Medicina clínica

1 reference

30 April 2018

volume

122

1 reference

30 April 2018

issue

14

1 reference

30 April 2018

page(s)

542-551

1 reference

30 April 2018

[Genetic studies of obesity in humans]

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The human obesity gene map: the 2003 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Mutational analysis of the coding region of the uncoupling protein 2 gene in obese NIDDM patients: impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

A polymorphism in the 5' untranslated region and a Met229-->Leu variant in exon 5 of the human UCP1 gene are associated with susceptibility to type II diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Frequency and significance of the A-->G (-3826) polymorphism in the promoter of the gene for uncoupling protein-1 with regard to metabolic parameters and adipocyte transcription factor binding in a large population-based Caucasian cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Association of -3826 G variant in uncoupling protein-1 with increased BMI in overweight Australian women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

DNA polymorphism in the uncoupling protein 1 (UCP1) gene has no effect on obesity related phenotypes in the Swedish Obese Subjects cohorts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-Heidelberg cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Phenotypic characterization of the beta3-adrenergic receptor mutation and the uncoupling protein 1 polymorphism in Japanese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Studies of the synergistic effect of the Trp/Arg64 polymorphism of the beta3-adrenergic receptor gene and the -3826 A-->G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a population-based sample of 379 youn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Association of sets of alleles of genes encoding beta3-adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Additive effects of the mutations in the beta3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Synergistic effect of polymorphisms in uncoupling protein 1 and β3-adrenergic receptor genes on long-term body weight change in Finnish type 2 diabetic and non-diabetic control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

No relationship between identified variants in the uncoupling protein 2 gene and energy expenditure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Lack of association between the uncoupling protein-2 Ala55Val gene polymorphism and phenotypic features of the Metabolic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Molecular screening of uncoupling protein 2 gene in patients with noninsulin-dependent diabetes mellitus or obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Screening for variants of the uncoupling protein 2 gene in Japanese patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Mutation screening of the human UCP 2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP 2 polymorphisms and obesity in French Caucasians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Genetic factors as predictors of weight gain in young adult Dutch men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

An untranslated insertion variant in the uncoupling protein 2 gene is not related to body mass index and changes in body weight during a 26-year follow-up in Danish Caucasian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Frequency of and interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

A 45‐bp Insertion/Deletion Polymorphism of Uncoupling Protein 2 in Relation to Obesity in Tongans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Linkage Between Markers in the Vicinity of the Uncoupling Protein 2 Gene and Resting Metabolic Rate in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Linkage exclusion analysis of the chromosome 11 region containing UCP2 and UCP3 with obesity-related phenotypes in Mexican Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Uncoupling protein 2 region on chromosome 11q13 is not linked to markers of obesity in familial type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Association between uncoupling protein 3 gene and obesity-related phenotypes in the Québec Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Uncoupling protein 3 gene is associated with body composition changes with training in HERITAGE study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Organisation of the coding exons and mutational screening of the uncoupling protein 3 gene in subjects with juvenile-onset obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

A genetic variation in the 5' flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

A prevalent polymorphism in the promoter of the UCP3 gene and its relationship to body mass index and long term body weight change in the Danish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Skeletal muscle UCP2 and UCP3 expression in trained and untrained male subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Uncoupling protein 3 and peroxisome proliferator-activated receptor gamma2 contribute to obesity and diabetes in palauans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Racial differences in the relation between uncoupling protein genes and resting energy expenditure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Evidence for gene-nutrient interaction at the PPARgamma locus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARgamma gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Analysis of the Relationship between PPAR-γ 2 Gene Variants and Severe Insulin Resistance in Obese Patients with Impaired Glucose Tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Pilot study examining the frequency of several gene polymorphisms in a morbidly obese population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-naïve patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Two Polymorphisms in the Peroxisome Proliferator-Activated Receptor- Gene Are Associated with Severe Overweight among Obese Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Frequency and significance of Pro12Ala and Pro115Gln polymorphism in gene for peroxisome proliferation-activated receptor-gamma regarding metabolic parameters in a Caucasian cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Effect of Trp64Arg mutation of the β3‐adrenergic receptor gene and C161T substitution of the peroxisome proliferator activated receptor γ gene on obesity in Japanese children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The human obesity gene map: the 2002 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

No effect of the Trp64Arg beta(3)-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, caucasian postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The risk of obesity and the Trp64Arg polymorphism of the beta(3)-adrenergic receptor: effect modification by age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

TRP64ARG polymorphism of the beta3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The polymorphism of the beta3-adrenergic receptor gene is associated with reduced low-density lipoprotein particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The beta 3-adrenergic receptor gene and obesity in a population sample of African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The Trp64Arg Polymorphism of the 3-Adrenergic Receptor Gene: Lack of association with NIDDM and features of insulin resistance syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The sympathetic nervous system and obesity: role in aetiology and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene are not associated with obesity in Japanese men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Effects of beta2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The Arg16Gly polymorphism of human beta2-adrenoreceptor is associated with type 2 diabetes in Taiwanese people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Interactions among the α2-, β2-, and β3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Tumor necrosis factor-alpha--308 G/A polymorphism in obese Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The effect of the -308A allele of the TNF-alpha gene on insulin action is dependent on obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The TNF alpha/G-308A polymorphism influences insulin sensitivity in offspring of patients with coronary heart disease: the European Atherosclerosis Research Study II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Genetic Variation and Obesity in Australian Women: A Prospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

G-308A polymorphism of the tumor necrosis factor alpha gene promoter and salivary cortisol secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The TNF-alpha gene NcoI polymorphism at position -308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Circulating ghrelin levels are decreased in human obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Role of ghrelin polymorphisms in obesity based on three different studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

Human hormone-sensitive lipase: genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

The hormone-sensitive lipase i6 gene polymorphism and body fat accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

A common hormone-sensitive lipase i6 gene polymorphism is associated with decreased human adipocyte lipolytic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2804%2974300-6

10.1016/S0025-7753(04)74300-6

7 January 2021

Identifiers

DOI

1 reference

30 April 2018

PubMed ID

15117649

1 reference

30 April 2018